Research Topics
| Vivian E von GruenigenSummaryAffiliation: Case Western Reserve University Country: USA Publications
| Collaborators
|
Detail Information
Publications
A case of chronic paclitaxel administration in ovarian cancerVivian E von Gruenigen
Division of Gynecologic Oncology, University MacDonald Women s Hospital University Hospitals of Cleveland and the Ireland Cancer Center, Case Western Reserve University, Cleveland, OH 44106, USA
Gynecol Oncol 89:532-5. 2003..When ovarian cancer recurs, chemotherapy is continued when patients respond to therapy. However, the disease may become stable. Stable disease is clinically relevant and no longer an indication of treatment failure...- Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma : a Gynecologic Oncology Group studyVivian E von Gruenigen
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University Hospitals of Cleveland, MacDonald Women s Hospital, and the Ireland Cancer Center, Cleveland, Ohio 44106, USA
Cancer 107:2786-91. 2006..The objective was to examine whether rates of disease recurrence, treatment-related adverse effects, and survival differed between obese or morbidly obese and nonobese patients... - The in vitro antitumor activity of vitamins C and K3 against ovarian carcinomaVivian E von Gruenigen
Department of Obstetrics and Gynecology, Summa Health System, 525 E Market Street, Akron, OH 44309, USA
Anticancer Res 23:3279-87. 2003..The objective was to evaluate the cytotoxic effect and mechanism of action of vitamins C (VC) and K3 (VK3) on ovarian carcinoma... - Clinical disease course during the last year in ovarian cancerVivian E von Gruenigen
University Hospitals of Cleveland MacDonald Women s Hospital, Ireland Cancer Center, Case Western Reserve University, Cleveland, OH 44016, USA
Gynecol Oncol 90:619-24. 2003..The objective was to determine whether there were changes in the pattern and nature of hospitalizations during the last year that could be used in the assessment of whether chemotherapy should be continued... - Futility: clinical decisions at the end-of-life in women with ovarian cancerVivian E von Gruenigen
Department of Reproductive Biology, Division of Gynecologic Oncology, University MacDonald Women s Hospital, 11100 Euclid Avenue, Cleveland, OH 44106, USA
Gynecol Oncol 97:638-44. 2005.... - Longitudinal assessment of quality of life and lifestyle in newly diagnosed ovarian cancer patients: the roles of surgery and chemotherapyVivian E von Gruenigen
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University Hospitals of Cleveland, OH 44106, USA
Gynecol Oncol 103:120-6. 2006..To prospectively evaluate quality of life (QoL), use of complementary and alternative medicine (CAM), and diet/exercise changes in ovarian cancer patients during the first 6 months following diagnosis... - The impact of obesity and age on quality of life in gynecologic surgeryVivian E von Gruenigen
University Hospitals of Cleveland, MacDonald Womens Hospital, The Ireland Cancer Center, Cleveland, OH, USA
Am J Obstet Gynecol 193:1369-75. 2005..This study was undertaken to prospectively evaluate the effect of early stage endometrial cancer, age, and obesity on quality of life (QOL)... - Gynecologic oncology patients' satisfaction and symptom severity during palliative chemotherapyVivian E von Gruenigen
University Hospitals Case Medical Center, Cleveland, Ohio 44106, USA
Health Qual Life Outcomes 4:84. 2006..The objective was to assess the association between patient's satisfaction with care and symptom severity and to evaluate test-retest of a satisfaction survey in this study population... - Assessment of factors that contribute to decreased quality of life in Gynecologic Oncology Group ovarian cancer trialsVivian E von Gruenigen
Department of Reproductive Biology, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, Ohio 44106, USA
Cancer 115:4857-64. 2009..The objective of this study was to assess which quality-of-life (QOL) line items on the Functional Assessment of Cancer Therapy-Ovarian (FACT-O) were associated with low QOL in women who were receiving chemotherapy for ovarian cancer... - The association between quality of life domains and overall survival in ovarian cancer patients during adjuvant chemotherapy: a Gynecologic Oncology Group StudyVivian E von Gruenigen
Summa Health System, 525 East Market Med II, POB 2090, Akron, OH 44309, USA
Gynecol Oncol 124:379-82. 2012..To explore the association between baseline quality of life (QOL) scores and overall survival (OS) in ovarian cancer patients receiving adjuvant chemotherapy... - Feasibility of a lifestyle intervention for ovarian cancer patients receiving adjuvant chemotherapyVivian E von Gruenigen
Summa Health System Akron City Hospital, Akron, OH 44309, USA
Gynecol Oncol 122:328-33. 2011..This study aimed to assess the feasibility of a lifestyle intervention for promoting physical activity (PA) and diet quality during adjuvant chemotherapy for ovarian cancer... - A comparison of quality-of-life domains and clinical factors in ovarian cancer patients: a Gynecologic Oncology Group studyVivian E von Gruenigen
Department of Reproductive Biology, University Hospitals Case Medical Center, Cleveland, Ohio 44106, USA
J Pain Symptom Manage 39:839-46. 2010..Women diagnosed with ovarian cancer are at risk for reduced quality of life (QOL). It is imperative to further define these declines to interpret treatment outcomes and design appropriate clinical interventions... - Effect of method of administration on longitudinal assessment of quality of life in gynecologic cancer: an exploratory studyKaren M Gil
Department of Obstetrics and Gynecology, Akron General Medical Center, Akron, Ohio, USA
Health Qual Life Outcomes 3:6. 2005..This study examined whether changes measured using a computer version of the Functional Assessment of Cancer Therapy - General (FACT-G) on two occasions would be obtained if patients completed a paper version on one of the two occasions... - A randomized trial of a lifestyle intervention in obese endometrial cancer survivors: quality of life outcomes and mediators of behavior changeVivian E von Gruenigen
University Hospitals Case Medical Center, Cleveland, OH, USA
Health Qual Life Outcomes 7:17. 2009..To examine the effects of a 6 month lifestyle intervention on quality of life, depression, self-efficacy and eating behavior changes in overweight and obese endometrial cancer survivors... - Baseline characteristics influencing quality of life in women undergoing gynecologic oncology surgeryKaren M Gil
Department of Obstetrics and Gynecology, Akron General Medical Center, Akron, Ohio 44302, USA
Health Qual Life Outcomes 5:25. 2007.... - Palliative and end-of-life care for patients with ovarian cancerSteven M Radwany
Summa Health System, Palliative Care and Hospice Services, Akron, Ohio, USA
Clin Obstet Gynecol 55:173-84. 2012..End-of-life care focuses on comfort, control, meaning, and support that become particularly intense when death is imminent... - Physical activity and gynecologic cancer survivorshipKaren M Gil
Akron General Medical Center, Akron, OH, USA
Recent Results Cancer Res 186:305-15. 2011..The effects of increased PA on recurrence or survival in gynecological cancers are not yet established, and randomized controlled trials are needed for definitive data... - Lifestyle challenges in endometrial cancer survivorshipVivian E von Gruenigen
Summa Health System Akron City Hospital, Akron, Ohio 44309, USA
Obstet Gynecol 117:93-100. 2011..To examine lifestyle behaviors that may contribute to endometrial cancer survivor morbidity and to identify associations with quality of life... - Microscopic aspects of autoschizic cell death in human ovarian carcinoma (2774) cells following vitamin C, vitamin K3 or vitamin C:K3 treatmentJacques Gilloteaux
Department of Urology, Summa Health System, Akron, OH 44304, USA
Microsc Microanal 9:311-29. 2003..These results also suggest that the vitamin combination may find clinical use in the treatment of ovarian cancer... - A review of issues surrounding quality of life among women with ovarian cancerLucybeth Nieves Arriba
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Cleveland Clinic, Cleveland, OH, USA
Gynecol Oncol 119:390-6. 2010..This trend has placed increasing attention upon the quality of life (QoL). The aim of this study was to review the existing literature on QoL, including measurement tools, and to explore opportunities to optimize well-being... - Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorshipAmanda Nickles Fader
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University Hospitals Case Medical Center, Cleveland, OH 44106, USA
Gynecol Oncol 114:121-7. 2009.... - A phase I/II study of extended field radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in patients with cervical carcinoma metastatic to the para-aortic lymph nodes: a Gynecologic Oncology Group studyJoan L Walker
Division of Gynecologic Oncology, University of Oklahoma, Oklahoma City, OK 73190, USA
Gynecol Oncol 112:78-84. 2009..To determine the maximum tolerated dose (MTD) of weekly paclitaxel and cisplatin chemotherapy concurrent with extended field irradiation in women with cervical cancer metastatic to the para-aortic nodes... - Feasibility and effectiveness of a lifestyle intervention program in obese endometrial cancer patients: a randomized trialVivian E von Gruenigen
University Hospitals Case Medical Center, Division of Gynecologic Oncology, 11100 Euclid Avenue, Room 7128, Cleveland, Ohio 44106, USA
Gynecol Oncol 109:19-26. 2008..The purpose of this study was to assess feasibility of a lifestyle intervention program for promoting weight loss, change in eating behaviors, and increased physical activity in obese ECS... - Body weight and composition changes in ovarian cancer patients during adjuvant chemotherapyKaren M Gil
Department of Obstetrics and Gynecology, Akron General Medical Center, 224 West Exchange Street, Akron, OH 44302, USA
Gynecol Oncol 103:247-52. 2006..To prospectively examine body weight changes in women with newly diagnosed ovarian cancer receiving surgery and adjuvant chemotherapy. Body composition was examined in a subset of these women... - Treatment patterns by decade of life in elderly women (> or =70 years of age) with ovarian cancerDenise Uyar
Department of Obstetrics and Gynecology, Division of Gynecology Oncology, Medical College of Wisconsin, WI, USA
Gynecol Oncol 98:403-8. 2005..CONCLUSION: The extreme elderly had a decreased likelihood of receiving surgery and combination chemotherapy despite equivalent co-morbidities. In this analysis, optimal surgical cytoreduction had the greatest impact on survival... - Surgical treatments for vulvar and vaginal dysplasia: a randomized controlled trialVivian E von Gruenigen
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University Hospital Case Medical Center, Case School of Medicine, Cleveland, Ohio, USA
Obstet Gynecol 109:942-7. 2007..To compare pain, adverse effects and recurrence of dysplasia in patients with vaginal intraepithelial neoplasia or vulvar intraepithelial neoplasia prospectively treated by carbon dioxide laser or ultrasonic surgical aspiration... - The effect of sleep disturbance on quality of life in women with ovarian cancerSamith Sandadi
Department of Obstetrics and Gynecology, University Hospitals Case Medical Center, Cleveland, OH 44106, USA
Gynecol Oncol 123:351-5. 2011..To estimate the prevalence of sleep disturbances, and to determine if there is an association between sleep disturbances with quality of life (QOL), depression or clinical demographic variables... - Toxicity of weekly oral topotecan in relation to dosage for gynecologic malignancies: a phase I studyVivian E von Gruenigen
Department of Obstetrics and Gynecology, Summa Akron City Hospital, Akron, Ohio 44309, USA
Anticancer Drugs 23:724-30. 2012..6, 41.3) had stable disease. An oral topotecan dose of 14 mg/week for 3 consecutive weeks out of 4 is mostly associated with acceptable toxicities and may be considered for use in future single-agent phase II trials... - Quality of life in endometrial cancer survivors: what does obesity have to do with it?Amanda Nickles Fader
Division of Gynecologic Oncology, Greater Baltimore Medical Center Johns Hopkins Hospital, Baltimore, MD 21204, USA
Obstet Gynecol Int 2011:308609. 2011..This paper highlights the importance of incorporating health-related QOL assessments and obesity interventions during the survivorship period...